Name: Bioworkshops sell "Panitumumab"
Brand: Bioworkshops
Availability: InStock

588

4.0(3)

Category

Subcategory & Sub-subcategory

Trade Type

Sell

Product Name

Panitumumab

Manufacturer(s)

Specifications

Regulatory Status: Developed from a cell line with DMF filing in place, ensuring global regulatory readiness for this EGFR antagonist mAb (originator: Amgen, first approved 2006-09-27, United States; representative indication: metastatic colorectal carcinoma).
Purity: Demonstrates a high degree of analytical comparability to the reference product, supporting regulatory and clinical acceptance as a biosimilar.
Expression System: Produced from an optimized, high-titer mammalian cell line and process delivering consistently strong productivity for cost-efficient large-scale manufacturing, with broad media adaptability across multiple platforms.

Bioworkshops sell "Panitumumab"

Ratings